Bank Of Montreal Abcam PLC Transaction History

Bank Of Montreal

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	BUY	$21.54 - $24.41 $31.3 Million - $35.5 Million	1,453,013 Added 372.11%	1,843,496 $41.7 Million
Q2 2023 Aug 02, 2023	BUY	$12.62 - $24.47 $3.55 Million - $6.89 Million	281,632 Added 258.73%	390,483 $9.56 Million
Q1 2023 Jun 13, 2024	BUY	$12.98 - $17.1 $1.44 Million - $1.9 Million	111,217 New	111,217 $1.5 Million
Q4 2022 Feb 01, 2023	SELL	$13.92 - $17.0 $41,495 - $50,677	-2,981 Reduced 2.67%	108,851 $1.69 Million
Q3 2022 Nov 10, 2022	SELL	$13.36 - $16.75 $12,758 - $15,996	-955 Reduced 0.85%	111,832 $1.87 Million
Q2 2022 Aug 11, 2022	BUY	$12.69 - $19.25 $25,684 - $38,962	2,024 Added 1.83%	112,787 $1.69 Million
Q1 2022 May 12, 2022	BUY	$15.5 - $23.89 $74,942 - $115,508	4,835 Added 4.56%	110,763 $2.06 Million
Q4 2021 Feb 11, 2022	BUY	$20.04 - $23.84 $19,158 - $22,791	956 Added 0.91%	105,928 $2.53 Million
Q3 2021 Nov 12, 2021	SELL	$17.38 - $21.54 $709,851 - $879,758	-40,843 Reduced 28.01%	104,972 $2.21 Million
Q2 2021 Aug 12, 2021	BUY	$18.47 - $22.11 $2.69 Million - $3.22 Million	145,815 New	145,815 $3.84 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.